Equities

Inspira Technologies Oxy BHN Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IINN:NAQ

Inspira Technologies Oxy BHN Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.5889
  • Today's Change0.000 / -0.02%
  • Shares traded264.80k
  • 1 Year change-35.37%
  • Beta2.2926
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

  • Revenue in USD (TTM)289.00k
  • Net income in USD-11.21m
  • Incorporated2018
  • Employees38.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Phaos Technlgy Hldngs (Cayman) Limited132.98k-100.00bn14.53m--------109.26-------0.0605------------------------0.3176------------------
United Health Products Inc0.00-2.95m16.43m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Envoy Medical Inc208.00k-28.61m17.27m42.00------83.04-1.44-1.440.0103-0.32180.02370.501.794,952.38-247.90-------294.23---10,475.00--0.4582-14.86-----28.80--10.55------
Retractable Technologies Inc37.90m-6.68m19.79m221.00--0.258523.800.5221-0.223-0.2231.272.560.24921.864.43171,495.80-4.248.45-4.509.59-2.4238.19-17.0115.054.54--0.0126---24.19-4.59-67.29--17.90--
Milestone Scientific Inc8.93m-6.67m20.76m17.00--8.14--2.32-0.0823-0.08230.10990.03250.90840.489614.06525,265.90-67.82-48.29-122.68-62.1471.8665.25-74.66-81.560.5103-837.640.2518---12.190.602731.97--0.40--
Adagio Medical Holdings Inc137.00k-79.15m20.86m86.00------152.28-4.75-4.750.0087-0.08530.0020.75583.041,593.02-114.09---130.69---1,468.61---57,771.53--0.6798-4.931.07--100.67---105.09------
Inspira Technologies Oxy BHN Ltd289.00k-11.21m21.83m38.00--13.20--75.55-0.4606-0.46060.01280.04460.04170.52810.66597,605.26-161.61-109.16-302.02-145.380.692---3,879.24--0.9002--0.00------2.06--39.54--
Jin Medical International Ltd22.83m1.79m21.92m269.0012.230.785211.110.96010.01150.01150.14580.17830.5093.264.1584,857.363.8510.686.3416.5135.7934.537.5513.921.90--0.36170.0018.572.9027.710.155496.27--
IRIDEX Corp50.65m-5.09m23.72m93.00------0.4684-0.3026-0.30263.020.27461.733.437.74544,591.40-17.39-20.28-33.62-29.9638.1842.41-10.04-15.171.35--0.4418---6.172.306.90---36.71--
Global Innovative Platforms Inc0.00-718.26k23.84m52.00--120.87-----0.0179-0.01790.000.00420.00-------720.78---929.61--------------0.0079-------427.35------
PetVivo Holdings Inc1.41m-9.65m24.72m24.00--5.81--17.54-0.402-0.4020.05920.12690.33370.626110.3758,701.67-224.88-195.28-343.15-346.3378.8874.58-673.99-1,163.491.45-4.230.00--16.91216.0823.33--49.21--
Harvard Bioscience Inc87.37m-53.84m24.80m330.00--1.76--0.2839-1.22-1.221.980.31560.83521.587.01264,760.60-51.46-4.48-81.52-5.4756.9457.18-61.62-6.180.4081-0.56860.7071---16.14-4.12-263.25--21.83--
Wellgistics Health Inc34.08m-77.75m25.02m31.00--3.68--0.7341-1.32-1.320.61610.07580.6293.6317.53---143.52---365.21--7.86---228.17--0.1628-16.420.7854-------136.77------
Guided Therapeutics Inc178.00k-2.80m26.75m4.00------150.29-0.0386-0.03860.0025-0.06750.16540.108344.5044,500.00-244.61-129.80----62.9244.19-1,478.65-4,184.720.0334-4.13-----92.86-27.9331.07------
Baird Medical Investment Holdings Ltd31.86m-3.12m28.28m143.00--0.5745--0.8876-0.1128-0.11281.221.340.45523.270.8459222,797.30-4.48---7.64--86.94---9.84--1.67-0.3230.3856--17.74--18.57------
Data as of Feb 13 2026. Currency figures normalised to Inspira Technologies Oxy BHN Ltd's reporting currency: US Dollar USD

Institutional shareholders

6.12%Per cent of shares held by top holders
HolderShares% Held
Yorkville Advisors Global LPas of 31 Dec 20251.78m4.99%
Citadel Securities LLCas of 30 Sep 202582.57k0.23%
Kestra Advisory Services LLCas of 31 Dec 202578.82k0.22%
XTX Markets LLCas of 30 Sep 202568.46k0.19%
Quadrature Capital Ltd.as of 30 Sep 202557.09k0.16%
UBS Securities LLCas of 31 Dec 202553.34k0.15%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 202525.93k0.07%
Laidlaw Wealth Management LLCas of 30 Sep 202513.50k0.04%
StoneX Group, Inc. (Investment Management)as of 31 Dec 202510.28k0.03%
Equitable Advisors LLCas of 30 Sep 202510.00k0.03%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.